Nanobiotix (NBTX) Total Non-Current Liabilities: 2019-2024

Historic Total Non-Current Liabilities for Nanobiotix (NBTX) over the last 5 years, with Dec 2024 value amounting to $79.3 million.

  • Nanobiotix's Total Non-Current Liabilities rose 3.39% to $57.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $57.8 million, marking a year-over-year increase of 3.39%. This contributed to the annual value of $79.3 million for FY2024, which is 59.79% up from last year.
  • According to the latest figures from FY2024, Nanobiotix's Total Non-Current Liabilities is $79.3 million, which was up 59.79% from $49.6 million recorded in FY2023.
  • In the past 5 years, Nanobiotix's Total Non-Current Liabilities ranged from a high of $79.3 million in FY2024 and a low of $45.1 million during FY2021.
  • Its 2-year average for Total Non-Current Liabilities is $64.4 million, with a median of $64.4 million in 2023.
  • As far as peak fluctuations go, Nanobiotix's Total Non-Current Liabilities declined by 11.23% in 2021, and later skyrocketed by 59.79% in 2024.
  • Over the past 4 years, Nanobiotix's Total Non-Current Liabilities (Yearly) stood at $50.8 million in 2020, then fell by 11.23% to $45.1 million in 2021, then reached $49.6 million in 2023, then skyrocketed by 59.79% to $79.3 million in 2024.